DoW Prostate Cancer, Early Investigator Research Award | Apply Online

FY26 PCRP Early Investigator Research Award (EIRA) FAQs

What is the FY26 Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA)?

The FY26 PCRP Early Investigator Research Award (EIRA) is a U.S. Department of Defense grant opportunity intended to help launch the careers of new investigators conducting prostate cancer research. It is designed to pair a focused prostate cancer research project with structured mentorship and a formal plan for building the skills needed to become an independent researcher.

What is the main purpose of the EIRA mechanism?

The EIRA is meant to provide early-career investigators with genuine leadership experience as a principal investigator (PI), along with targeted support and mentorship. The program emphasizes both the quality of the proposed prostate cancer research and the applicant's career development toward research independence.

What research topics are appropriate for this award?

Projects are expected to be directly tied to prostate cancer. In addition, each application must explicitly address one of the FY26 PCRP Overarching Challenges, which serve as the program's high-level priority problem areas for that fiscal year.

Does the project have to address a specific program priority?

Yes. A defining expectation is that the proposed work must explicitly address one of the FY26 PCRP Overarching Challenges. Applications should make that connection clear rather than implying alignment indirectly.

Who is eligible to serve as the principal investigator (PI)?

The PI must be an early-career researcher as defined by training stage, not age. Applicants must have a doctoral degree (or equivalent) and have fewer than three years of postdoctoral research experience by the application submission deadline.

How is "early-career" defined for this opportunity?

Eligibility is based on postdoctoral research experience. To qualify, the applicant must have fewer than three years of postdoctoral research experience by the application submission deadline, and must also hold a doctoral degree or equivalent.

Does time spent in clinical residency or clinical fellowship count toward the postdoctoral research experience limit?

No. Time spent in clinical residency or clinical fellowship training does not count toward the postdoctoral research experience limit, which can be particularly relevant for clinician-scientists transitioning into research.

Can the early investigator apply as a co-investigator while a senior researcher serves as PI?

No. The early investigator must serve as the PI. The award is intended to provide true PI-level leadership experience rather than placing the applicant under another investigator's grant leadership.

Is mentorship required for an EIRA application?

Yes. Mentorship is not optional. Each application must include at least one mentor.

What are the mentor requirements?

Each application must include at least one mentor who has demonstrated expertise in prostate cancer research and a track record of successful mentorship. Reviewers are expected to consider whether the mentoring structure is credible and likely to support the PI's development.

What is the mentor expected to do in this award?

The mentor typically provides scientific guidance, helps shape rigorous experimental or analytical approaches, and supports professional development. This may include advice related to publications, collaborations, and planning for next-step funding, consistent with the program's emphasis on building independence.

What is the Researcher Development Plan and is it required?

The Researcher Development Plan is a required component of the application. It is an individualized plan describing how the PI will acquire the skills, competencies, and expertise needed to execute the proposed research and advance toward independence.

What should a strong Researcher Development Plan cover?

A competitive plan connects the PI's current gaps to concrete development activities. Examples mentioned for potential skill areas include biostatistics, clinical trial design, advanced imaging, omics methods, and computational approaches. The plan can include mentored training, coursework, workshops, structured milestones, and regular feedback mechanisms.

Will the application be evaluated only on the science?

No. Based on the program description, reviewers are expected to consider both the proposed research and the investigator's growth, including the credibility of mentorship and the quality of the Researcher Development Plan.

What agency is offering this grant opportunity?

This is a U.S. Department of Defense opportunity. Administratively, it is described as a discretionary grant under the Defense Health Agency Contracting Activity (DHACA).

What is the CFDA number associated with this opportunity?

The opportunity is listed under CFDA 12.420.

What is the funding opportunity number?

The funding opportunity number is HT942526PCRPEIRA.

Who can apply (what types of organizations are eligible)?

The eligible applicant category is described as unrestricted, suggesting that a wide range of institutions and organizations may apply as long as they meet the program requirements described for the mechanism.

When was this opportunity created and what is the deadline?

The opportunity was created on May 21, 2026. The original closing date is September 2, 2026.

How many awards does the program expect to make?

The program anticipates making about 14 awards.

What is the maximum award amount (award ceiling)?

The award ceiling is not provided in the source information shown. Applicants would need to consult the full announcement or related program guidance for budget limits, the period of performance, and allowable costs.

Where can applicants find details on allowable costs, performance period, and budget limits?

The provided information indicates these details are not included in the source data shown. Applicants should consult the full announcement or related PCRP program guidance to confirm budget limits, period of performance, and allowable costs.